Abstract
IntroductionImmune checkpoint inhibitors (ICI) have revolutionized the treatment of metastatic malignant melanoma (MM) and improved long-term survival. Despite the impressive results, some patients still have progressive disease, and the search...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have